A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites

Journal of Applied Toxicology

Volumn 32, Issue 3, 2012, Pages 153-185

  Nagarajan, M ^a   Maruthanayagam, V ^a   Sundararaman, M ^a  

^a BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Apoptosis; Cytoskeletal proteins; Cytotoxic; Marine cyanobacteria; Membrane transporters; Proteases

Indexed keywords

ANKARAHOLIDE A; ANTILLATOXIN; APRATOXIN A; APRATOXIN B; APRATOXIN C; APRATOXIN D; APRATOXIN E; APRATOXIN F; APRATOXIN G; AURILIDE; AURILIDE B; AURILIDE C; BACTERIAL TOXIN; BISEBROMOAMIDE; BISELYNGBYASIDE; CALOTHRIXIN A; CALOTHRIXIN B; CARMABIN A; CAYLOBOLIDE A; CAYLOBOLIDE B; COIBAMIDE A; CROSSBYANOL A; CURACIN A; DOLASTATIN 10; DRAGOMABIN; KULOKEKAHILIDE 2; MALYNGAMIDE D; MALYNGAMIDE E; MARINE TOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BACTERIUM ISOLATION; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; BURKITT LYMPHOMA; CALCIUM SIGNALING; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HEK293; CELL STRAIN HT29; CELL STRAIN MCF 7; COLON ADENOCARCINOMA; CYTOTOXICITY; HELA CELL; HUMAN; IC 50; LD 50; LEUKEMIA CELL LINE; LUNG CANCER; LYNGBYA; LYNGBYA BOUILLONII; LYNGBYA CONFERVOIDES; LYNGBYA CROSSBYANA; LYNGBYA MAJUSCULA; LYNGBYA POLYCHROA; LYNGBYA SORDIDA; MARINE BACTERIUM; MELANOMA CELL; MICROFILAMENT; MINIMUM INHIBITORY CONCENTRATION; NASOPHARYNX CARCINOMA; NEUROBLASTOMA CELL; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CYANOBACTERIA; CYTOSKELETON; HUMANS; ION CHANNELS; NEUROTOXINS; PROTEASE INHIBITORS;

ALGAE; CYANOBACTERIA; FUNGI; MOLLUSCA; PROTOZOA;

EID: 84856414687     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1717     Document Type: Review

References (207)

1. Adams B, Porzgen P, Pittman E, Yoshida WY, Westenburg HE, Horgen FD. 2008. Isolation and structure determination of malevamide E, a dolastatin 14 analogue, from the marine cyanobacterium Symploca laete-viridis. J. Nat. Prod. 71: 750-754.
2. Admi V, Afek U, Carmeli S. 1996. Raocyclamides A and B, novel cyclic hexapeptides isolated from the cyanobacterium Oscillatoria raoi. J. Nat. Prod. 59: 396-399.
3. Andrianasolo EH, Gross H, Goeger D, Musafija-Girt M, McPhail K, Leal RM, Mooberry SL, Gerwick WH. 2005. Isolation of swinholide A and related glycosylated derivatives from two field collections of marine cyanobacteria. Org. Lett. 7: 1375-1378.
4. Aráoz R, Molgó J, de Marsac NT. 2010. Neurotoxic cyanobacterial toxins. Toxicon. 56: 813-828.
5. Arthur KE, Limpus CJ, Roelfsema CM, Udy JW, Shaw GR. 2006. A bloom of Lyngbya majuscula in Shoalwater Bay, Queensland, Australia: an important feeding ground for the green turtle (Chelonia mydas). Harmful Algae. 5: 251-265.
6. Balunas MJ, Linington RG, Tidgewell K, Fenner AM, Urena L, Togna GD, Kyle DE, Gerwick WH. 2010. Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity. J. Nat. Prod. 73: 60-66.
7. Banker R, Carmeli S. 1998. Tenuecyclamides A-D, cyclic hexapeptides from the cyanobacterium Nostoc spongiaeforme var. tenue. J. Nat. Prod. 61: 1248-1251.
8. Belkacemi L, Bedard I, Simoneau L, Lafond J. 2005. Calcium channels, transporters and exchangers in placenta: a review. Cell Calcium. 37: 1-8.
9. Berman FW, Gerwick WH, Murray TF. 1999. Antillatoxin and kalkitoxin, ichthyotoxins from the tropical cyanobacterium Lyngbya majuscula, induce distinct temporal patterns of NMDA receptor-mediated neurotoxicity. Toxicon. 37: 1645-1648.
10. Bowers A, West N, Taunton J, Schreiber SL, Bradner JE, Williams RM. 2008. Total synthesis and biological mode of action of largazole: a potent class I histone deacetylase inhibitor. J. Am. Chem. Soc. 130: 11219-11222.
11. Buenz EJ, Howe CL. 2007. Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo. Neurotoxicology. 28: 702-704.
12. Bui HTN, Jansen R, Pham HTL, Mundt S. 2007. Carbamidocyclophanes A-E, chlorinated paracyclophanes with cytotoxic and antibiotic activity from the Vietnamese cyanobacterium Nostoc sp. J. Nat. Prod. 70: 499-503.
13. Bunyajetpong S, Yoshida WY, Sitachitta N, Kaya K. 2006. Trungapeptins A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 69: 1539-1542.
14. Capper A, Paul VJ. 2008. Grazer interactions with four species of Lyngbya in southeast Florida. Harmful Algae. 7: 717-728.
15. Capper A, Cruz-Rivera E, Paul VJ, Tibbetts IR. 2006. Chemical deterrence of a marine cyanobacterium against sympatric and non-sympatric consumers. Hydrobiologia. 553: 319-326.
16. Carmichael WW, Li RH. 2006. Cyanobacteria toxins in the Salton Sea. Saline Syst. 2: 5. doi: 10.1186/1746-1448-2-5.
17. Cestele S, Catterall WA. 2000. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimica 82: 883-892.
18. Chang TT, More SV, Lu I, Hsu J, Chen T, Jen YC, Lu C, Li W. 2011. Isomalyngamide A, A-1 and their analogs suppress cancer cell migration in vitro. Eur. J. Med. Chem. doi: 10.1016/j.ejmech.2011.05.049.
19. Chlipala GE, Tri PH, Hung NV, Krunic A, Shim SH, Soejarto DD, Orjala J. 2010. Nhatrangins A and B, aplysiatoxin-related metabolites from the marine cyanobacterium Lyngbya majuscula from Vietnam. J. Nat. Prod. 73: 784-787.
20. Choi H, Engene N, Smith JE, Preskitt LB, Gerwick WH. 2010a. Crossbyanols A-D, toxic brominated polyphenyl ethers from the Hawaiian bloom-forming cyanobacterium Leptolyngbya crossbyana. J. Nat. Prod. 73: 517-522.
21. Choi H, Pereira AR, Cao Z, Shuman CF, Engene N, Byrum T, Matainaho T, Murray TF, Mangoni A, Gerwick WH. 2010b. The hoiamides, structurally intriguing neurotoxic lipopeptides from Papua New Guinea marine cyanobacteria. J. Nat. Prod. 73: 1411-1421.
22. Clare JJ. 2006. Discovery of novel sodium channel inhibitors-A gene family-based approach. Comp. Biochem. Physiol. Part D Genomics Proteomics. 1: 309-318.
23. Clark BR, Engene N, Teasdale ME, Rowley DC, Matainaho T, Valeriote FA, Gerwick WH. 2008. Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum. J. Nat. Prod. 71: 1530-1537.
24. Cox PA, Banack SA, Murch SJ, Rasmussen U, Tien G, Bidigare RR, Metcalf JS, Morrison LF, Codd GA, Bergman B. 2005. Diverse taxa of cyanobacteria produce β-N-methylamino-l-alanine, a neurotoxic amino acid. Proc. Natl Acad. Sci. 102: 5074-5078.
25. da Rosa CE, de Souza MS, Yunes JS, Proenca LAO, Nery LEM, Monserrat JM. 2005. Cyanobacterial blooms in estuarine ecosystems: characteristics and effects on Laeonereis acuta (Polychaeta, Nereididae). Mar. Pollut. Bull. 50: 956-964.
26. Davies WR, Siu WHL, Jack RW, Wu RSS, Lam PKS, Nugegoda D. 2005. Comparative effects of the blue green algae Nodularia spumigena and a lysed extract on detoxification and antioxidant enzymes in the green lipped mussel (Perna viridis). Mar. Pollut. Bull. 51: 1026-1033.
27. Davies-Coleman MT, Dzeha TM, Gray CA, Hess S, Pannell LK, Hendricks DT, Arendse CE. 2003. Isolation of homodolastatin 16, a new cyclic depsipeptide from a Kenyan collection of Lyngbya majuscula. J. Nat. Prod. 66: 712-715.
28. Edwards DJ, Marquez BL, Nogle LM, McPhail K, Goeger DE, Roberts MA, Gerwick WH. 2004. Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula. Chem. Biol. 11: 817-833.
29. Fernández R, Rodríguez J, Quiñoá E, Riguera R, Muñoz L, Fernández-Suárez M, Debitus C. 1996. Onchidin B: A new cyclodepsipeptide from the mollusc Onchidium sp. J. Am. Chem. Soc. 118:11635-11643.
30. Flatt PM, Gautschi JT, Thacker RW, Musafija-Girt M, Crews P, Gerwick WH. 2005. Identification of the cellular site of polychlorinated peptide biosynthesis in the marine sponge Dysidea (Lamellodysidea) herbacea and symbiotic cyanobacterium Oscillatoria spongeliae by CARD-FISH analysis. Mar. Biol. 147: 761-774.
31. Frias-Lopez J, Bonheyo GT, Jin Q, Fouke BW. 2003. Cyanobacteria associated with coral black band disease in Caribbean and Indo-Pacific reefs. Appl. Environ. Microbiol. 69: 2409-2413.
32. Gerwick WH, Proteau PJ, Nagle DG, Hamel E, Blokhin A, Slate DL. 1994. Structure of curacin A a novel antimitotic, antiproliferative and brine shrimp toxic natural product from the marine cyanobacterium Lyngbya majuscula. J. Org. Chem. 59: 1243-1245.
33. Goode BL, Drubin DG, Barnes G. 2000. Functional cooperation between the microtubule and actin cytoskeletons. Curr. Opin. Cell Biol. 12: 63-71.
34. Graber MA, Gerwick WH. 1998. Kalkipyrone, a toxic γ-pyrone from an assemblage of the marine cyanobacteria Lyngbya majuscula and Tolypothrix sp. J. Nat. Prod. 61: 677-680.
35. Gross H, McPhail KL, Goeger DE, Valeriote FA, Gerwick WH. 2010. Two cytotoxic stereoisomers of malyngamide C, 8-epi-malyngamide C and 8-O-acetyl-8-epi-malyngamide C, from the marine cyanobacterium Lyngbya majuscula. Phytochemistry. 71: 1729-1735.
36. Gunasekera SP, Ross C, Paul VJ, Matthew S, Luesch H. 2008. Dragonamides C and D, linear lipopeptides from the marine cyanobacterium brown Lyngbya polychroa. J. Nat. Prod. 71: 887-890.
37. Gunasekera SP, Miller MW, Kwan JC, Luesch H, Paul VJ. 2010. Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis. J. Nat. Prod. 73: 459-462.
38. Gunasekera SP, Owle CS, Montaser R, Luesch H, Paul VJ. 2011. Malyngamide 3 and cocosamides A and B from the marine cyanobacterium Lyngbya majuscula from Cocos Lagoon, Guam. J. Nat. Prod.. doi: .
39. Gutiérrez M, Suyama TL, Engene N, Wingerd JS, Matainaho T, Gerwick WH. 2008. Apratoxin D, a potent cytotoxic cyclodepsipeptide from Papua New Guinea collections of the marine cyanobacteria Lyngbya majuscula and Lyngbya sordida. J. Nat. Prod. 71: 1099-1103.
40. Gutiérrez M, Tidgewell K, Capson TL, Engene N, Almanza A, Schemies J, Jung M, Gerwick WH. 2010. Malyngolide dimer, a bioactive symmetric cyclodepside from the Panamanian marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 73: 709-711.
41. Gutiérrez Mandrianasolo EH, Shin WK, Goeger DE, Yokochi A, Schemies J, Jung M, France D, Cornell-Kennon S, Lee E, Gerwick WH. 2009. Structural and synthetic investigations of tanikolide dimer, a SIRT2 selective inhibitor, and tanikolide seco-acid from the Madagascar marine cyanobacterium Lyngbya majuscula. J. Org. Chem. 74: 5267-5275.
42. Han B, McPhail KL, Ligresti A, Marzo VD, Gerwick WH. 2003. Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J. Nat. Prod. 66: 1364-1368.
43. Han B, Goeger D, Maier CS, Gerwick WH. 2005a. The wewakpeptins, cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J. Org. Chem. 70: 3133-3139.
44. Han B, McPhail KL, Gross H, Goeger DE, Mooberry SL, Gerwick WH. 2005b. Isolation and structure of five lyngbyabellin derivatives from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. Tetrahedron 61: 11723-11729.
45. Han B, Gross H, Goeger DE, Mooberry SL, Gerwick WH. 2006. Aurilides B and C, cancer cell toxins from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 69: 572-575.
46. Harrigan GG, Yoshida WY, Moore RE, Nagle DG, Park PU, Biggs J, Paul VJ, Mooberry SL, Corbett TH, Valeriote FA. 1998a. Isolation, structure determination and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages. J. Nat. Prod. 61: 1221-1225.
47. Harrigan GG, Luesch H, Yoshida WY, Moore RE, Nagle DG, Paul VJ, Mooberry SL, Corbett TH, Valeriote FA. 1998b. Symplostatin 1: a dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides. J. Nat. Prod. 61: 1075-1077.
48. Harrigan GG, Luesch H, Yoshida WY, Moore RE, Nagle DG, Paul VJ. 1999. Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides. J. Nat. Prod. 62: 655-658.
49. Harrigan GG, Goetz GH, Luesch H, Yang S, Likos J. 2001. Dysideaprolines A-F and barbaleucamides A-B, novel polychlorinated compounds from a Dysidea species. J. Nat. Prod. 64: 1133-1138.
50. Herfindal L, Myhren L, Kleppe R, Krakstad C, Selheim F, Jokela J, Sivonen K, Døskeland SO. 2011. Nostocyclopeptide-M1: a potent, nontoxic inhibitor of the hepatocyte drug transporters OATP1B3 and OATP1B1. Mol. Pharm. 8: 360-367.
51. Horgen FD, Kazmierski EB, Westenburg HE, Yoshida WY, Scheuer PJ. 2002. Malevamide D: isolation and structure determination of an isodolastatin H analogue from the marine cyanobacterium Symploca hydnoides. J. Nat. Prod. 65: 487-491.
52. Iwasaki A, Teruya T, Suenaga K. 2010. Isolation and structure of koshikalide, a 14-membered macrolide from the marine cyanobacterium Lyngbya sp. Tetrahedron Lett. 51: 959-960.
53. Jimenez JI, Scheuer PJ. 2001. New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod. 64: 200-203.
54. Jimenez JI, Vansach T, Yoshida WY, Sakamoto B, Porzgen P, Horgen FD. 2009. Halogenated fatty acid amides and cyclic depsipeptides from an eastern Caribbean collection of the cyanobacterium Lyngbya majuscula. J. Nat. Prod. 72: 1573-1578.
55. Joanitti GA, Azevedo RB, Freitas SM. 2010. Apoptosis and lysosome membrane permeabilization induction on breast cancer cells by an anticarcinogenic Bowman-Birk protease inhibitor from Vigna unguiculata seeds. Cancer Lett. 293: 73-81.
56. Kan Y, Fujita T, Nagai H, Sakamoto B, Hokama Y. 1998. Malyngamide M and N from Hawaiian red alga Gracilaria coronopifolia. J. Nat. Prod. 61: 152-155.
57. Kan Y, Sakamoto B, Fujita T, Nagai H. 2000. New malyngamides from the Hawaiian cyanobacterium Lyngbya majuscula. J. Nat. Prod. 63: 1599-1602.
58. Kankaanpaa H, Vuorinen PJ, Sipia V, Keinanen M. 2002. Acute effects and bioaccumulation of nodularin in sea trout (Salmo trutta m. trutta L.) exposed orally to Nodularia spumigena under laboratory conditions. Aquat. Toxicol. 61: 155-168.
59. Kankaanpaa HT, Holliday J, Schroder H, Goddard TJ, Fister RV, Carmichael WW. 2005. Cyanobacteria and prawn farming in northern New South Wales, Australia - a case study on cyanobacteria diversity and hepatotoxin bioaccumulation. Toxicol. Appl. Pharmacol. 203: 243-256.
60. Karjalainen M, Kozlowsky-Suzuki B, Lehtiniemi M, Engstrom-Ost J, Kankaanpaa H, Viitasalo M. 2006. Nodularin accumulation during cyanobacterial blooms and experimental depuration in zooplankton. Mar. Biol. 148: 683-691.
61. Karjalainen M, Paakkonen J, Peltonen H, Sipia V, Valtonen T, Viitasalo M. 2008. Nodularin concentrations in Baltic Sea zooplankton and fish during a cyanobacterial bloom. Mar. Biol. 155: 483-491.
62. Karlsson O, Roman E, Berg AL, Brittebo EB. 2011. Early hippocampal cell death, and late learning and memory deficits in rats exposed to the environmental toxin BMAA (β-N-methylamino-l-alanine) during the neonatal period. Behav. Brain Res. 219: 310-320.
63. Khan QA, Lu J, Hecht SM. 2009. Calothrixins, a new class of human DNA topoisomerase I poisons. J. Nat. Prod. 72: 438-442.
64. Kochegarov AA. 2003. Pharmacological modulators of voltage-gated calcium channels and their therapeutical application. Cell Calcium. 33: 145-162.
65. Korpinen S, Karjalainen M, Viitasalo M. 2006. Effects of cyanobacteria on survival and reproduction of the littoral crustacean Gammarus zaddachi (Amphipoda). Hydrobiologia 559: 285-295.
66. Kozlowsky-Suzuki B, Koski M, Hallberg E, Wallen R, Carlsson P. 2009. Glutathione transferase activity and oocyte development in copepods exposed to toxic phytoplankton. Harmful Algae. 8: 395-406.
67. Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H. 2009a. Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. J. Med. Chem. 52: 5732-5747.
68. Kwan JC, Taori K, Paul VJ, Luesch H. 2009b. Lyngbyastatins 8-10, elastase inhibitors with cyclic depsipeptide scaffolds isolated from the marine cyanobacterium Lyngbya semiplena. Mar. Drugs. 7: 528-538.
69. Kwan JC, Teplitski M, Gunasekera SP, Paul VJ, Luesch H. 2010a. Isolation and biological evaluation of 8-epi-malyngamide C from the Floridian marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 73: 463-466.
70. Kwan JC, Ratnayake R, Abboud KA, Paul VJ, Luesch H. 2010b. Grassypeptolides A-C, cytotoxic bis-thiazoline containing marine cyclodepsipeptides. J. Org. Chem. 75: 8012-8023.
71. Landsberg J, Dolah FV, Doucette G. 2005. Marine and estuarine harmful algal blooms: impacts on human and animal health. In Oceans and Health: Pathogens in the Marine Environment, Belkin S, Colwell RR (eds). Springer: New York; 165-215.
72. Large CH, Kalinichev M, Lucas A, Carignani C, Bradford A, Garbati N, Sartori I, Austin NE, Ruffo A, Jones DNC, Alvaro G, Read KD. 2009. The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat. Epilepsy Res. 85: 96-106.
73. Leão JC, Geracitano LA, Monserrat JM, Amado LL, Yunes JS. 2008. Microcystin-induced oxidative stress in Laeonereis acuta (Polychaeta, Nereididae). Mar. Environ. Res. 66: 92-94.
74. LePage KT, Goeger D, Yokokawa F, Asano T, Shioiri T, Gerwick WH, Murray TF. 2005. The neurotoxic lipopeptide kalkitoxin interacts with voltage-sensitive sodium channels in cerebellar granule neurons. Toxicol. Lett. 158: 133-139.
75. Li WI, Berman FW, Okino T, Yokokawa F, Shioiri T, Gerwick WH, Murray TF. 2001. Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels. Proc. Natl Acad. Sci.. 98: 7599-7604.
76. Li WI, Marquez BL, Okino T, Yokokawa F, Shioiri T, Gerwick WH, Murray TF. 2004. Characterization of the preferred stereochemistry for the neuropharmacologic actions of antillatoxin. J. Nat. Prod. 67: 559-568.
77. Linington RG, Gonzalez J, Urena L, Romero LI, Ortega-Barria E, Gerwick WH. 2007. Venturamides A and B: antimalarial constituents of the Panamanian marine cyanobacterium Oscillatoria sp. J. Nat. Prod. 70: 397-401.
78. Linington RG, Edwards DJ, Shuman CF, McPhail KL, Matainaho T, Gerwick WH. 2008. Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine cyanobacterium Symploca sp. J. Nat. Prod. 71: 22-27.
79. Linington RG, Clark BR, Trimble EE, Almanza A, Urena L, Kyle DE, Gerwick WH. 2009. Antimalarial peptides from marine cyanobacteria: isolation and structural elucidation of gallinamide A. J. Nat. Prod. 72: 14-17.
80. Liu Y, Law BK, Luesch H. 2009. Apratoxin A reversibly inhibits the secretory pathway by preventing cotranslational translocation. Mol. Pharmacol. 76: 91-104.
81. Llewellyn LE. 2006. Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Nat. Prod. Rep. 23: 200-222.
82. Lobner D, Piana PMT, Salous AK, Peoples RW. 2007. β-N-methylamino-l-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol. Dis. 25: 360-366.
83. Loya S, Reshef V, Mizrachi E, Silberstein C, Rachamim Y, Carmeli S, Hizi A. 1998. The inhibition of the reverse transcriptase of HIV-1 by the natural sulfoglycolipids from cyanobacteria: contribution of different moieties to their high potency. J. Nat. Prod. 61: 891-895.
84. Luesch H, Yoshida WY, Moore RE, Paul VJ. 1999. Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 62: 1702-1706.
85. Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL. 2000a. Isolation, structure determination, and biological activity of lyngbyabellin A from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 63: 611-615.
86. Luesch H, Yoshida WY, Moore RE, Paul VJ. 2000b. Isolation and structure of the cytotoxin lyngbyabellin b and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 63: 1437-1439.
87. Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH. 2001a. Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1. J. Nat. Prod. 64: 907-910.
88. Luesch H, Pangilinan R, Yoshida WY, Moore RE, Paul VJ. 2001b. Pitipeptolides A and B, new cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 64: 304-307.
89. Luesch H, Yoshida WY, Moore RE, Paul VJ, Corbet TH. 2001c. Total structure determination of apratoxin A, a poten novel cytotoxin from the marine cyanobacterium Lyngbya majuscula. J. Am. Chem. Soc. 123: 5418-5423.
90. Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL, Corbett TH. 2002a. Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452. J. Nat. Prod. 65: 16-20.
91. Luesch H, Williams PG, Yoshida WY, Moore RE, Paul VJ. 2002b. Ulongamides A-F, new β-amino acid-containing cyclodepsipeptides from Palauan collections of the marine cyanobacterium Lyngbya sp. J. Nat. Prod. 65: 996-1000.
92. Luesch H, Yoshida WY, Harrigan GG, Doom JP, Moore RE, Paul VJ. 2002c. Lyngbyaloside B, a new glycoside macrolide from a Palauan marine cyanobacterium, Lyngbya sp. J. Nat. Prod. 65: 1945-1948.
93. Luesch H, Yoshida WY, Moore RE, Paul VJ. 2002d. New apratoxins of marine cyanobacterial origin from Guam and Palau. Bioorg. Med. Chem. 10: 1973-1978.
94. Luesch H, Yoshida WY, Moore RE, Paul VJ. 2002e. Structurally diverse new alkaloids from Palauan collections of apratoxin-producing marine cyanobacterium Lyngbya sp. Tetrahedron. 58: 7959-7966.
95. Luesch H, Chanda SK, Raya RM, DeJesus PD, Orth AP, Walker JR, Belmonte JCI, Schultz PG. 2006. A functional genomics approach to the mode of action of apratoxin A. Nat. Chem. Biol. 2: 158-167.
96. MacMillan JB, Molinski TF. 2002. Caylobolide A, a unique 36-membered macrolactone from a Bahamian Lyngbya majuscula. Org. Lett. 4: 1535-1538.
97. MacMillan JB, Molinski TF. 2005. Majusculoic acid, a brominated cyclopropyl fatty acid from a marine cyanobacterial mat assemblage. J. Nat. Prod. 68: 604-606.
98. MacMillan JB, Ernst-Russell MA, Ropp JS, Molinski TF. 2002. Lobocyclamides A-C, lipopeptides from a cryptic cyanobacterial mat containing Lyngbya confervoides. J. Org. Chem. 67: 8210-8215.
99. MacMillan JB, Xiong-Zhou G, Skepper CK, Molinski TF. 2008. Phorbasides A-E, cytotoxic chlorocyclopropane macrolide glycosides from the marine sponge Phorbas sp. CD determination of c-methyl sugar configurations. J. Org. Chem. 73: 3699-3706.
100. Magalhaes VF, Marinho MM, Domingos P, Oliveira AC, Costa SM, Azevedo LO, Azevedo SMFO. 2003. Microcystins (cyanobacteria hepatotoxins) bioaccumulation in fish and crustaceans from Sepetiba Bay (Brasil, RJ). Toxicon. 42: 289-295.
101. Malloy KL, Villa FA, Engene N, Matainaho T, Gerwick L, Gerwick WH. 2011. Malyngamide 2, an oxidized lipopeptide with nitric oxide inhibiting activity from a Papua New Guinea marine cyanobacterium. J. Nat. Prod. 74: 95-98.
102. Marquez BL, Watts KS, Yokochi A, Roberts MA, Verdier-Pinard P, Jimenez JI, Hamel E, Scheuer PJ, Gerwick WH. 2002. Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly. J. Nat. Prod. 65: 866-871.
103. Maru N, Ohno O, Uemura D. 2010. Lyngbyacyclamides A and B, novel cytotoxic peptides from marine cyanobacteria Lyngbya sp. Tetrahedron Lett. 51: 6384-6387. doi: 10.1016/j.tetlet.2010.06.105.
104. Matthew S, Ross C, Rocca JR, Paul VJ, Luesch H. 2007. Lyngbyastatin 4, a dolastatin 13 analogue with elastase and chymotrypsin inhibitory activity from the marine cyanobacterium Lyngbya confervoides. J. Nat. Prod. 70: 124-127.
105. Matthew S, Schupp PJ, Luesch H. 2008a. Apratoxin E, a cytotoxic peptolide from a Guamanian collection of the marine cyanobacterium Lyngbya bouillonii. J. Nat. Prod. 71: 1113-1116.
106. Matthew S, Ross C, Paul VJ, Luesch H. 2008b. Pompanopeptins A and B, new cyclic peptides from the marine cyanobacterium Lyngbya confervoides. Tetrahedron. 64: 4081-4089.
107. Matthew S, Paul VJ, Luesch H. 2009. Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides. Phytochemistry. 70: 2058-2063.
108. Matthew S, Salvador LA, Schupp PJ, Paul VJ, Luesch H. 2010. Cytotoxic halogenated macrolides and modified peptides from the apratoxin-producing marine cyanobacterium Lyngbya bouillonii from Guam. J. Nat. Prod. 73: 1544-1552.
109. Mayer AMS, Gustafson KR. 2006. Marine pharmacology in 2003-2004: anti-tumour and cytotoxic compounds. Eur. J. Cancer. 42: 2241-2270.
110. McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barria E, Capson TL, Gerwick WH. 2007. Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 70: 984-988.
111. Medina RA, Goeger DE, Hills P, Mooberry SL, Huang N, Romero LI, Ortega-Barria E, Gerwick WH, McPhail KL. 2008. Coibamide A, a potent antiproliferative cyclic depsipeptide from the Panamanian marine cyanobacterium Leptolyngbya sp. J. Am. Chem. Soc. 130: 6324-6325.
112. Mesguiche V, Valls R, Piovetti L, Peiffer G. 1999. Characterization and synthesis of (-)-7-methoxydodec-4(E)-enoic acid, a novel fatty acid isolated from Lyngbya majuscula. Tetrahedron Lett. 40: 7473-7476.
113. Mevers E, Liu W, Engene N, Mohimani H, Byrum T, Pevzner PA, Dorrestein PC, Spadafora C, Gerwick WH. 2011. Cytotoxic veraguamides, alkynyl bromide-containing cyclic depsipeptides from the marine cyanobacterium cf. Oscillatoria margaritifera. J. Nat. Prod. doi: 10.1021/np200077f
114. Milligan KE, Márquez B, Williamson RT, Davies-Coleman M, Gerwick WH. 2000a. Two new malyngamides from a Madagascan Lyngbya majuscula. J. Nat. Prod. 63: 965-968.
115. Milligan KE, Márquez BL, Williamson RT, Gerwick WH. 2000b. Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 63: 1440-1443.
116. Mitchell SS, Faulkner DJ, Rubins K, Bushman FD. 2000. Dolastatin 3 and two novel cyclic peptides from a Palauan collection of Lyngbya majuscula. J. Nat. Prod. 63: 279-282.
117. Mitra A, Sept D. 2004. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin. Biochem. 43: 13955-13962.
118. Mo S, Krunic A, Pegan SD, Franzblau SG, Orjala J. 2009. An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp. J. Nat. Prod. 72: 2043-2045.
119. Montaser R, Abboud KA, Paul VJ, Luesch H. 2011. Pitiprolamide, a proline-rich dolastatin 16 analogue from the marine cyanobacterium Lyngbya majuscula from Guam. J. Nat. Prod. 74: 109-112.
120. Muller D, Krick A, Kehraus S, Mehner C, Hart M, Kupper FC, Saxena K, Prinz H, Schwalbe H, Janning P, Waldmann H, Gabriele M, Konig GM. 2006. Brunsvicamides A-C: sponge-related cyanobacterial peptides with Mycobacterium tuberculosis protein tyrosine phosphatase inhibitory activity. J. Med. Chem. 49: 4871-4878.
121. Myers JL, Sekar R, Richardson LL. 2007. Molecular detection and ecological significance of the cyanobacterial genera Geitlerinema and Leptolyngbya in black band disease of corals. Appl. Environ. Microbiol. 73: 5173-5182.
122. Mynderse JS, Moore RE. 1978. Malyngamides D and E, two trans-7-methoxy-9-methylhexadec-4-enamides from a deep water variety of the marine cyanophyte Lyngbya majuscula. J. Org. Chem. 43: 4359-4363.
123. Nagle DG, Paul VJ. 1998. Chemical defence of a marine cyanobacterial bloom. J. Exp. Mar. Biol. Ecol. 225: 29-38.
124. Nagle DG, Camacho FT, Paul VJ. 1998. Dietary preferences of the opisthobranch mollusc Stylocheilus longicauda for secondary metabolites produced by the tropical cyanobacterium Lyngbya majuscula. Mar. Biol. 132: 267-273.
125. Nagle DG, Zhou Y, Park PU, Paul VJ, Rajbhandari I, Duncan CJG, Pasco DS. 2000. A new indanone from the marine cyanobacterium Lyngbya majuscula that inhibits hypoxia-induced activation of the VEGF promoter in Hep3B cells. J. Nat. Prod. 63: 1431-1433.
126. Nakao Y, Yoshida WY, Szabo CM, Baker BJ, Scheuer PJ. 1998. More peptides and other diverse constituents of the marine mollusk Philinopsis speciosa. J. Org. Chem. 63: 3272-3280.
127. Nakao Y, Yoshida WY, Takada Y, Kimura J, Yang L, Mooberry SL, Scheuer PJ. 2004. Kulokekahilide-2, a cytotoxic depsipeptide from a cephalaspidean mollusk Philinopsis speciosa. J. Nat. Prod. 67: 1332-1340.
128. Nascimento FJA, Karlson AML, Naslund J, Gorokhova E. 2009. Settling cyanobacterial blooms do not improve growth conditions for soft bottom meiofauna. J. Exp. Mar. Biol. Ecol. 368: 138-146.
129. Newman DJ, Cragg GM. 2004. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 67: 1216-1238.
130. Nogle LM, Gerwick WH. 2002a. Isolation of four new cyclic depsipeptides, antanapeptins A-D, and dolastatin 16 from a Madagascan collection of Lyngbya majuscula. J. Nat. Prod. 65: 21-24.
131. Nogle LM, Gerwick WH. 2002b. Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage. Org. Lett. 4: 1095-1098.
132. Nogle LM, Okino T, Gerwick WH. 2001a. Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 64: 983-985.
133. Nogle LM, Williamson RT, Gerwick WH. 2001b. Somamides A and B, two new depsipeptide analogues of dolastatin 13 from a Fijian cyanobacterial assemblage of Lyngbya majuscula and Schizothrix species. J. Nat. Prod. 64: 716-719.
134. Nunn PB, Ponnusamy M. 2009. β-N-Methylaminoalanine (BMAA): metabolism and metabolic effects in model systems and in neural and other tissues of the rat in vitro. Toxicon. 54: 85-94.
135. Orjala J, Gerwick WH. 1996. Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod. 59: 427-430.
136. Orjala J, Nagel D, Gerwick WH. 1995. Malyngamide H, an ichthyotoxic amide possessing a new carbon skeleton from the Caribbean cyanobacterium Lyngbya majuscula. J. Nat. Prod. 58: 764-768.
137. Pandey R, Patil N, Rao M. 2007. Proteases and protease inhibitors: implications in antitumourigenesis and drug development. Int. J. Hum. Genet. 7: 67-82.
138. Pereira A, Cao Z, Murray TF, Gerwick WH. 2009. Hoiamide A, a sodium channel activator of unusual architecture from a consortium of two Papua New Guinea cyanobacteria. Chem. Biol. 16: 893-906.
139. Pereira AR, McCue CF, Gerwick WH. 2010a. Cyanolide A, a glycosidic macrolide with potent molluscicidal activity from the Papua New Guinea cyanobacterium Lyngbya bouilloni. J. Nat. Prod. 73: 217-220.
140. Pereira AR, Cao Z, Engene N, Soria-Mercado IE, Murray TF, Gerwick WH. 2010b. Palmyrolide A, an unusually stabilized neuroactive macrolide from Palmyra Atoll cyanobacteria. Org. Lett. 12: 4490-4493.
141. Pereira AR, Etzbach L, Engene N, Muller R, Gerwick WH. 2011. Molluscicidal metabolites from an assemblage of Palmyra Atoll cyanobacteria. J. Nat. Prod. doi: .
142. Pérez-Linares J, Cadena M, Rangel C, Unzueta-Bustamante M, Ochoa J. 2003. Effect of Schizothrix calcicola on white shrimp Litopenaeus vannamei (Penaeus vannamei) postlarvae. Aquac. 218: 55-65.
143. Pettit GR, Hogan F, Herald DL. 2004. Synthesis and X-ray crystal structure of the Dolabella auricularia peptide dolastatin 18. J. Org. Chem. 69: 4019-4022.
144. Pflugmacher S, Wiegand C, Werner S, Schroder H, Kankaanpaa H. 2005. Activity and substrate specificity of cytosolic and microsomal glutathione S-transferase in Australian black tiger prawns (Penaeus monodon) after exposure to cyanobacterial toxins. Environ. Toxicol. 20: 301-307.
145. Pinho GLL, da Rosa CM, Yunes JS, Luquet CM, Bianchini A, Monserrat JM. 2003. Toxic effects of microcystins in the hepatopancreas of the estuarine crab Chasmagnathus granulatus (Decapoda, Grapsidae). Comp. Biochem. Physiol. C. 135: 459-468.
146. Plaza A, Bewley CA. 2006. Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp. J. Org. Chem. 71: 6898-6907.
147. Poncet J. 1999. The dolastatins, a family of promising antineoplasting agents. Curr. Pharm. Des. 5: 139-162.
148. Purdie EL, Samsudin S, Eddy FB, Codd GA. 2009. Effects of the cyanobacterial neurotoxin β-N-methylamino-l-alanine on the early-life stage development of zebrafish (Danio rerio). Aquat. Toxicol. 95: 279-284.
149. Ramaswamy AV, Sorrels CM, Gerwick WH. 2007. Cloning and biochemical characterization of the hectochlorin biosynthetic gene cluster from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 70: 1977-1986.
150. Rao SD, Banack SA, Cox PA, Weiss JH. 2006. BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp. Neurol. 201: 244-252.
151. Reinikainen M, Lindvall F, Meriluoto JAO, Repka S, Sivonen K, Spoof L, Wahlsten M. 2002. Effects of dissolved cyanobacterial toxins on the survival and egg hatching of estuarine calanoid copepods. Mar. Biol. 140: 577-583.
152. Rho M, Matsunaga K, Yasuda K, Ohizumi Y. 1996. A novel monogalactosylacylglycerol with inhibitory effect on platelet aggregation from the cyanophyceae Oscillatoria rosea. J. Nat. Prod. 59: 308-309.
153. Richardson LL, Sekar R, Myers JL, Gantar M, Voss JD, Kaczmarsky L, Remily ER, Boyer GL, Zimba PV. 2007. The presence of the cyanobacterial toxin microcystin in black band disease of corals. FEMS Microbiol. Lett. 272: 182-187.
154. Rickards RW, Rothschild JM, Willis AC, de Chazal NM, Kirk J, Kirk K, Saliba KJ, Smith GD. 1999. Calothrixins A and B, novel pentacyclic metabolites from Calothrix cyanobacteria with potent activity against malaria parasites and human cancer cells. Tetrahedron. 55: 13513-13520.
155. Rogers M, Tang L, Madge DJ, Stevens EB. 2006. The role of sodium channels in neuropathic pain. Cell Dev. Biol. 17: 571-581.
156. Rubio BK, Parrish SM, Yoshida W, Schupp PJ, Schils T, Williams PG. 2010. Depsipeptides from a Guamanian marine cyanobacterium, Lyngbya bouillonii, with selective inhibition of serine proteases. Tetrahedron Lett. 51: 6718-6721. doi: 10.1016/j.tetlet.2010.10.062
157. Salvador LA, Paul VJ, Luesch H. 2010. Caylobolide B, a macrolactone from symplostatin 1-producing marine cyanobacteria Phormidium spp. from Florida. J. Nat. Prod. 73: 1606-1609.
158. Salvador LA, Biggs JS, Paul VJ, Luesch H. 2011. Veraguamides A-G, Cyclic hexadepsipeptides from a dolastatin 16-producing cyanobacterium Symploca cf. hydnoides from Guam. J. Nat. Prod. doi: dx.doi.org/10.1021/np200076t
159. Sanchez LM, Lopez D, Vesely BA, Togna GD, Gerwick WH, Kyle DE, Linington RG. 2010. Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds. J. Med. Chem. 53: 4187-4197.
160. Sashidhara KV, White KN, Crews P. 2009. A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products. J. Nat. Prod. 72: 588-603.
161. Sato S, Murata A, Orihara T, Shirakawa T, Suenaga K, Kigoshi H, Uesugi M. 2011. Marine natural product aurilide activates the OPA1-mediated apoptosis by binding to prohibitin. Chem. Biol. 18: 131-139.
162. Schantz EJ, Ghazarossian VE, Schnoes HK, Strong FM, Springer JP, Pezzanite JO, Clardy J. 1975. The structure of saxitoxin. J. Am. Chem. Soc. 97: 1238-1239.
163. Simmons TL, McPhail KL, Ortega-Barría E, Mooberry SL, Gerwick WH. 2006. Belamide A, a new antimitotic tetrapeptide from a Panamanian marine cyanobacterium. Tetrahedron Lett. 47: 3387-3390.
164. Simmons TL, Engene N, Urena LD, Romero LI, Ortega-Barria E, Gerwick L, Gerwick WH. 2008. Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis. J. Nat. Prod. 71: 1544-1550.
165. Simmons TL, Nogle LM, Media J, Valeriote FA, Mooberry SL, Gerwick WH. 2009. Desmethoxymajusculamide C, a cyanobacterial depsipeptide with potent cytotoxicity in both cyclic and ring-opened forms. J. Nat. Prod. 72: 1011-1016.
166. Singh IP, Milligan KE, Gerwick WH. 1999. Tanikolide, a toxic and antifungal lactone from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 62: 1333-1335.
167. Sipia VO, Kankaanpaa HT, Pflugmacher S, Flinkman J, Furey A, James KJ. 2002. Bioaccumulation and detoxication of nodularin in tissues of flounder (Platichthys flesus), mussels (Mytilus edulis, Dreissena polymorpha) and clams (Macoma balthica) from the northern Baltic Sea. Ecotoxicol. Environ. Saf. 53: 305-311.
168. Sipia V, Kankaanpaa H, Peltonen H, Vinni M, Meriluoto J. 2007. Transfer of nodularin to three-spined stickleback (Gasterosteus aculeatus L.), herring (Clupea harengus L.) and salmon (Salmo salar L.) in the northern Baltic Sea. Ecotoxicol. Environ. Saf. 66: 421-425.
169. Sitachitta N, Gerwick WH. 1998. Grenadadiene and grenadamide, cyclopropyl-containing fatty acid metabolites from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 61: 681-684.
170. Sitachitta N, Williamson RT, Gerwick WH. 2000. Yanucamides A and B, two new depsipeptides from an assemblage of the marine cyanobacteria Lyngbya majuscula and Schizothrix Species. J. Nat. Prod. 63: 197-200.
171. Sorger PK, Dobles M, Tournebizet R, Hymant AA. 1997. Coupling cell division and cell death to microtubule dynamics. Curr. Opin. Cell Biol. 9: 807-814.
172. Soria-Mercado IE, Pereira A, Cao Z, Murray TF, Gerwick WH. 2009. Alotamide A, a novel neuropharmacological agent from the marine cyanobacterium Lyngbya bouillonii.Org. Lett. 11: 4704-4707.
173. Stierle DB, Stierle AA, Bugni T, Loewen G. 1998. Gloeolactone, a new epoxy lactone from a blue-green alga. J. Nat. Prod. 61: 251-252.
174. Sumiya E, Shimogawa H, Sasaki H, Tsutsumi M, Yoshita K, Ojika M, Suenaga K, Uesugi M. 2011. Cell-morphology profiling of a natural product library identifies bisebromoamide and miuraenamide A as actin filament stabilizers. ACS Chem. Biol.; doi:
175. Suntornchashwej S, Chaichit N, Isobe M, Suwanborirux K. 2005. Hectochlorin and morpholine derivatives from the Thai sea hare, Bursatella leachii. J. Nat. Prod. 68: 951-955.
176. Tan LT, Okino T, Gerwick WH. 2000. Hermitamides A and B, toxic malyngamide-type natural products from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 63: 952-955.
177. Tan LT, Marquez BL, Gerwick WH. 2002. Lyngbouilloside, a novel glycosidic macrolide from the marine cyanobacterium Lyngbya bouillonii. J. Nat. Prod. 65: 925-928.
178. Tan LT, Sitachitta N, Gerwick WH. 2003. The guineamides, novel cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 66: 764-771.
179. Tan LT, Chang YY, Ashootosh T. 2008. Besarhanamides A and B from the marine cyanobacterium Lyngbya majuscula. Phytochemistry. 69: 2067-2069.
180. Taniguchi M, Nunnery JK, Engene N, Esquenazi E, Byrum T, Dorrestein PC, Gerwick WH. 2010. Palmyramide A, a cyclic depsipeptide from a Palmyra Atoll collection of the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 73: 393-398.
181. Taori K, Matthew S, Rocca JR, Paul VJ, Luesch H. 2007. Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp. J. Nat. Prod. 70: 1593-1600.
182. Taori K, Paul VJ, Luesch H. 2008a. Kempopeptins A and B, serine protease inhibitors with different selectivity profiles from a marine cyanobacterium, Lyngbya sp. J. Nat. Prod. 71: 1625-1629.
183. Taori K, Paul VJ, Luesch H. 2008b. Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp. J. Am. Chem. Soc. 130: 1806-1807.
184. Taori K, Liu Y, Paul VJ, Luesch H. 2009. Combinatorial strategies by marine cyanobacteria: symplostatin 4, an antimitotic natural dolastatin 10/15 hybrid that synergizes with the coproduced HDAC inhibitor largazole. Chem. Bio. Chem. 10: 1634-1639.
185. Teruya T, Sasaki H, Fukazawa H, Suenaga K. 2009a. Bisebromoamide, a potent cytotoxic peptide from the marine cyanobacterium Lyngbya sp.: isolation, stereostructure, and biological activity. Org. Lett. 11: 5062-5065.
186. Teruya T, Sasaki H, Kitamura K, Nakayama T, Suenaga K. 2009b. Biselyngbyaside, a macrolide glycoside from the marine cyanobacterium Lyngbya sp. Org. Lett. 11: 2421-2424.
187. Tidgewell K, Engene N, Byrum T, Media J, Doi T, Valeriote FA, Gerwick WH. 2010. Evolved diversification of a modular natural product pathway: apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii. Chem. Bio. Chem. 11: 1458-1466.
188. Titlyanov EA, Titlyanova TV. 2008. Coral-algal competition on damaged reefs. Russ. J. Mar. Biol. 34: 199-219.
189. Tripathi A, Puddick J, Prinsep MR, Lee PPF, Tan LT. 2009. Hantupeptin A, a cytotoxic cyclic depsipeptide from a Singapore collection of Lyngbya majuscula. J. Nat. Prod. 72: 29-32.
190. Tripathi A, Puddick J, Prinsep MR, Lee PPF, Tan LT. 2010a. Hantupeptins B and C, cytotoxic cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. Phytochemistry. 71: 307-311.
191. Tripathi A, Puddick J, Prinsep MR, Rottmann M, Tan LT. 2010b. Lagunamides A and B: cytotoxic and antimalarial cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula. J. Nat. Prod. 73: 1810-1814.
192. Unson MD, Holland ND, Faulkner DJ. 1994. A brominated secondary metabolite synthesized by the cyanobacterial symbiont of a marine sponge and accumulation of the crystalline metabolite in the sponge tissue. Mar. Biol. 119: 1-11.
193. Velzeboer RMA, Baker PD, Rositano J, Heresztyn T, Codd GA, Raggett SL. 2000. Geographical patterns of occurrence and composition of saxitoxins in the cyanobacterial genus Anabaena (Nostocales, Cyanophyta) in Australia. Phycologia 39: 395-407.
194. Williams PG, Yoshida WY, Moore RE, Paul VJ. 2002a. Isolation and structure determination of obyanamide, a novel cytotoxic cyclic depsipeptide from the marine cyanobacterium Lyngbya confervoides. J. Nat. Prod. 65: 29-31.
195. Williams PG, Yoshida WY, Moore RE, Paul VJ. 2002b. Tasiamide, a cytotoxic peptide from the marine cyanobacterium Symploca sp. J. Nat. Prod. 65: 1336-1339.
196. Williams PG, Yoshida WY, Moore RE, Paul VJ. 2003a. Tasipeptins A and B: new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp. J. Nat. Prod. 66: 620-624.
197. Williams PG, Moore RE, Paul VJ. 2003b. Isolation and structure determination of lyngbyastatin 3, a lyngbyastatin 1 homologue from the marine cyanobacterium Lyngbya majuscula. Determination of the configuration of the 4-amino-2, 2-dimethyl-3-oxopentanoic acid unit in majusculamide C, dolastatin. J. Nat. Prod. 66: 1356-1363.
198. Williams PG, Yoshida WY, Quon MK, Moore RE, Paul VJ. 2003c. The structure of Palau'amide, a potent cytotoxin from a species of the marine cyanobacterium Lyngbya. J. Nat. Prod. 66: 1545-1549.
199. Williams PG, Yoshida WY, Quon MK, Moore RE, Paul VJ. 2003d. Ulongapeptin, a cytotoxic cyclic depsipeptide from a Palauan marine cyanobacterium Lyngbya sp. J. Nat. Prod. 66: 651-654.
200. Williams PG, Luesch H, Yoshida WY, Moore RE, Paul VJ. 2003e. Continuing studies on the cyanobacterium Lyngbya sp.: isolation and structure determination of 15-norlyngbyapeptin A and lyngbyabellin D. J. Nat. Prod. 66: 595-598.
201. Williamson RT, Boulanger A, Vulpanovici A, Roberts MA, Gerwick WH. 2002. Structure and absolute stereochemistry of phormidolide, a new toxic metabolite from the marine cyanobacterium Phormidium sp. J. Org. Chem. 67: 7927-7936.
202. Williamson RT, Singh IP, Gerwick WH. 2004. Taveuniamides: new chlorinated toxins from a mixed assemblage of marine cyanobacteria. Tetrahedron. 60: 7025-7033.
203. Wrasidlo W, Mielgo A, Torres VA, Barbero S, Stoletov K, Suyama TL, Klemke RL, Gerwick WH, Carson DA, Stupack DG. 2008. The marine lipopeptide somocystinamide A triggers apoptosis via caspase 8. Proc. Natl Acad. Sci. 105: 2313-2318.
204. Wu M, Okino T, Nogle LM, Marquez BL, Williamson RT, Sitachitta N, Berman FW, Murray TF, McGough K, Jacobs R, Colsen K, Asano T, Yokokawa F, Shioiri T, Gerwick WH. 2000. Structure, synthesis, and biological properties of kalkitoxin, a novel neurotoxin from the marine cyanobacterium Lyngbya majuscula. Toxicon. 122: 12041-12042.
205. Ying Y, Taori K, Kim H, Hong J, Luesch H. 2008. Total synthesis and molecular target of largazole, a histone deacetylase inhibitor. J. Am. Chem. Soc. 130: 8455-8459.
206. Yokokawa F, Shioiri T. 1998. Total synthesis of antillatoxin, an ichthyotoxic cyclic lipopeptide, having the proposed structure. what is the real structure of antillatoxin? J. Org. Chem. 63: 8638-8639.
207. Zainuddin EN, Jansen R, Nimtz M, Wray V, Preisitsch M, Lalk M, Mundt S. 2009. Lyngbyazothrins A-D, antimicrobial cyclic undecapeptides from the cultured cyanobacterium Lyngbya sp. J. Nat. Prod. 72: 1373-1378.